7Marutsuka T, Shimada S,Shiomori K ,et al. Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma : an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis[J].Clin Cancer Res,2003,9 (2) : 678-685.
8Yunning Huang, Akeo Hagiwara, Wei Wang, et al. Local injection of M-CH combined with i.p. hyperthermic hypo-osmolar infusion is an ectivc therapy in advanced gastric cancer [J].Anticancer Drugs, 2002,13( 14):431-435.
9Franco Roviello, Daniele Marrelli, Alessandro Neff. et al.Treatment of Peritoneal Carcinomatosis by Cytoreduetive Surgery and Intraperitoneal Hyperther mie Chemoperfusion (IHCP): Postoperative Outeome and Risk Faetors for Morbidity [J].World J Surg, 2006,30( 11 ):2033-2040.
10Cerretani D, Nencini C, Urso R. et al. Pharmacokinetics of Mitomycin C after resection of peritoneal carcinomatosis and intraperitoneal cbemohyperthermic perfusion [J].J Chemother, 2005,17:56-61.
3Cui S,Ba M,Tang Y,et al. B ultrasound-guided hyper- thermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites[J]. Oncology Reports,2012, 28(4) : 1325-1331.
4Siemeister G,Lacking U,Wengner AM,et al. BAY 1000394, A novel cyclin-dependent kinase inhibitor,with potent an- titumor activity in mono-and in combination treatment upon oral application[J]. Molecular Cancer Therapeutics, 2012,11 (10) : 2265-2273.
5Touil YS, Seguin J, Scherman D, et al. Improved antian- giogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice[J]. Cancer Chemother- apy and Pharmacology, 2011,68 (2) : 445-455.
